Lori Tipton, a trauma survivor, found relief from crippling anxiety and hypervigilance through MDMA-assisted therapy in a clinical trial for PTSD. The potential of psychoactive drugs like MDMA, LSD, and ketamine to treat mental illnesses is being explored through research and investment. However, challenges include validation of benefits, trial data integrity, accessibility, and safety concerns. FDA approval for MDMA-based treatment is pending, with questions about data integrity. Researchers are also exploring new treatments using artificial intelligence and analog compounds. The future potential of these therapies remains promising but faces various challenges and uncertainties.
Source link
Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In.
